Free Trial

Transdigm Group (TDG) Financials

Transdigm Group logo
$1,392.54 -36.61 (-2.56%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$1,395.00 +2.46 (+0.18%)
As of 08/8/2025 07:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Transdigm Group

Annual Income Statements for Transdigm Group

This table shows Transdigm Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2014 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Net Income / (Loss) Attributable to Common Shareholders
307 447 583 597 957 890 699 680 866 1,298 1,714
Consolidated Net Income / (Loss)
307 447 586 597 957 892 700 681 867 1,299 1,715
Net Income / (Loss) Continuing Operations
307 447 586 629 962 841 653 681 866 1,299 1,715
Total Pre-Tax Income
449 637 768 837 986 1,063 740 715 1,127 1,716 2,215
Total Operating Income
928 1,074 1,268 1,483 1,655 1,926 1,751 1,691 2,215 2,923 3,531
Total Gross Profit
1,268 1,450 1,728 1,985 2,177 2,809 2,647 2,513 3,099 3,842 4,672
Total Revenue
2,373 2,707 3,171 3,504 3,811 5,223 5,103 4,798 5,429 6,585 7,940
Operating Revenue
2,373 2,707 3,171 3,504 3,811 5,223 5,103 4,798 5,429 6,585 7,940
Total Cost of Revenue
1,105 1,257 1,443 1,520 1,634 2,414 2,456 2,285 2,330 2,743 3,268
Operating Cost of Revenue
1,105 1,257 1,443 1,520 1,634 2,414 2,456 2,285 2,330 2,743 3,268
Total Operating Expenses
340 376 460 502 522 883 896 822 884 919 1,141
Selling, General & Admin Expense
276 322 383 413 450 748 727 685 748 780 980
Amortization Expense
64 54 77 89 72 135 169 137 136 139 161
Total Other Income / (Expense), net
-479 -437 -500 -645 -669 -863 -1,011 -976 -1,088 -1,207 -1,316
Interest Expense
479 437 500 642 669 862 1,057 1,096 1,077 1,220 1,344
Other Income / (Expense), net
- - - -3.02 0.00 -1.00 46 120 -11 13 28
Income Tax Expense
142 190 182 209 24 222 87 34 261 417 500
Net Income / (Loss) Discontinued Operations
- 0.00 0.00 -32 -5.00 51 47 0.00 1.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - 0.00 0.00 2.00 1.00 1.00 1.00 1.00 1.00
Basic Earnings per Share
$3.16 $7.84 $10.39 $7.88 $16.20 $13.84 $8.96 $10.41 $13.40 $22.03 $25.62
Weighted Average Basic Shares Outstanding
56.99M 56.61M 56.16M 55.53M 55.60M 56.30M 57.30M 58.40M 58.20M 57.20M 57.80M
Diluted Earnings per Share
$3.16 $7.84 $10.39 $7.88 $16.20 $13.84 $8.96 $10.41 $13.40 $22.03 $25.62
Weighted Average Diluted Shares Outstanding
56.99M 56.61M 56.16M 55.53M 55.60M 56.30M 57.30M 58.40M 58.20M 57.20M 57.80M
Weighted Average Basic & Diluted Shares Outstanding
56.99M 56.61M 56.16M 55.53M 55.60M 56.30M 57.30M 58.40M 54.37M 55.31M 56.23M
Cash Dividends to Common per Share
$25.00 $0.00 $0.00 $46.00 $0.00 $30.00 $32.50 $0.00 $18.50 $0.00 $110.00

Quarterly Income Statements for Transdigm Group

This table shows Transdigm Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 12/31/2022 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/30/2024 12/28/2024 3/29/2025 6/28/2025
Net Income / (Loss) Attributable to Common Shareholders
228 304 351 415 382 403 461 468 493 479 492
Consolidated Net Income / (Loss)
229 304 352 414 382 404 461 468 493 479 493
Net Income / (Loss) Continuing Operations
229 304 352 414 382 404 461 468 493 479 493
Total Pre-Tax Income
301 397 469 549 488 519 602 606 619 622 635
Total Operating Income
590 695 783 855 787 867 934 943 974 991 1,039
Total Gross Profit
793 929 1,029 1,091 1,042 1,152 1,220 1,258 1,235 1,274 1,332
Total Revenue
1,397 1,592 1,744 1,852 1,789 1,919 2,046 2,186 2,006 2,150 2,237
Operating Revenue
1,397 1,592 1,744 1,852 1,789 1,919 2,046 2,186 2,006 2,150 2,237
Total Cost of Revenue
604 663 715 761 747 767 826 928 771 876 905
Operating Cost of Revenue
604 663 715 761 747 767 826 928 771 876 905
Total Operating Expenses
203 234 246 236 255 285 286 315 261 283 293
Selling, General & Admin Expense
169 199 209 203 220 248 248 264 211 236 242
Amortization Expense
34 35 37 33 35 37 38 51 50 47 51
Total Other Income / (Expense), net
-289 -298 -314 -306 -299 -348 -332 -337 -355 -369 -404
Interest Expense
290 300 323 307 300 354 346 344 378 378 404
Other Income / (Expense), net
1.00 2.00 9.00 1.00 1.00 6.00 14 7.00 23 9.00 0.00
Income Tax Expense
72 93 117 135 106 115 141 138 126 143 142
Net Income / (Loss) Attributable to Noncontrolling Interest
1.00 0.00 1.00 -1.00 0.00 1.00 0.00 - 0.00 0.00 1.00
Basic Earnings per Share
$3.33 $5.32 $6.14 $7.24 $4.87 $6.97 $7.96 $5.82 $7.62 $8.24 $8.47
Weighted Average Basic Shares Outstanding
57.10M 57.10M 57.20M 57.20M 57.70M 57.80M 57.90M 57.80M 58.30M 58.10M 58.10M
Diluted Earnings per Share
$3.33 $5.32 $6.14 $7.24 $4.87 $6.97 $7.96 $5.82 $7.62 $8.24 $8.47
Weighted Average Diluted Shares Outstanding
57.10M 57.10M 57.20M 57.20M 57.70M 57.80M 57.90M 57.80M 58.30M 58.10M 58.10M
Weighted Average Basic & Diluted Shares Outstanding
54.60M 54.93M 55.18M 55.31M 55.61M 55.96M 56.11M 56.23M 56.08M 56.17M 56.35M
Cash Dividends to Common per Share
$0.00 $0.00 $0.00 - $35.00 $0.00 $0.00 $75.00 $0.00 $0.00 $0.00

Annual Cash Flow Statements for Transdigm Group

This table details how cash moves in and out of Transdigm Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2014 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Net Change in Cash & Equivalents
-1,658 -569 873 -936 1,422 -606 3,250 70 -1,786 471 2,789
Net Cash From Operating Activities
273 120 683 789 1,022 1,015 1,213 913 948 1,375 2,045
Net Cash From Continuing Operating Activities
273 120 683 792 1,023 1,015 1,213 913 948 1,375 2,045
Net Income / (Loss) Continuing Operations
0.00 0.00 586 597 957 841 653 681 866 1,299 1,715
Consolidated Net Income / (Loss)
- - 586 597 957 892 700 681 867 1,299 1,715
Net Income / (Loss) Discontinued Operations
- 0.00 - - - 51 47 0.00 1.00 0.00 0.00
Depreciation Expense
33 36 43 51 57 91 114 115 116 129 149
Amortization Expense
64 58 94 132 101 202 202 178 174 148 189
Non-Cash Adjustments To Reconcile Net Income
158 50 64 117 60 91 107 29 105 227 284
Changes in Operating Assets and Liabilities, net
19 -24 -105 -104 -152 -210 137 -90 -313 -428 -292
Net Cash From Investing Activities
-346 -1,679 -1,443 -287 -684 -3,889 799 -785 -553 -900 -2,441
Net Cash From Continuing Investing Activities
-346 -1,679 -1,443 -287 -684 -3,889 799 -785 -553 -900 -2,441
Purchase of Property, Plant & Equipment
-34 -55 -44 -71 -73 -102 -105 -105 -119 -139 -165
Acquisitions
-312 -1,624 -1,399 -216 -668 -3,976 0.00 -963 -437 -762 -2,347
Divestitures
- - - - 57 189 904 259 3.00 1.00 71
Net Cash From Financing Activities
-1,585 993 1,632 -1,444 1,086 2,271 1,230 -70 -2,148 -16 3,171
Net Cash From Continuing Financing Activities
-1,585 993 1,632 -1,444 1,086 2,271 1,230 -70 -2,148 -16 3,171
Repayment of Debt
-0.03 -1,027 -838 -1,831 -12,185 -628 -1,253 -2,257 -277 -6,431 -1,988
Repurchase of Common Equity
-160 0.00 -208 -390 0.00 0.00 -19 0.00 -912 0.00 0.00
Payment of Dividends
-1,451 -3.37 -3.00 -2,582 -56 -1,712 -1,928 -73 -1,091 -38 -2,038
Issuance of Debt
0.00 1,961 2,651 3,338 13,269 4,529 4,314 2,132 0.00 6,238 6,952
Other Financing Activities, net
27 62 30 21 58 82 116 128 132 215 245
Other Net Changes in Cash
- - - - - - 8.00 12 -33 12 14
Cash Interest Paid
- - 449 588 635 878 923 1,008 1,057 1,160 1,158
Cash Income Taxes Paid
- 127 183 185 129 215 223 83 220 260 539

Quarterly Cash Flow Statements for Transdigm Group

This table details how cash moves in and out of Transdigm Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 12/31/2022 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/30/2024 12/28/2024 3/29/2025 6/28/2025
Net Change in Cash & Equivalents
287 1,230 -1,447 401 663 703 -1,478 2,901 -3,802 -33 366
Net Cash From Operating Activities
377 130 406 462 636 229 608 572 752 148 631
Net Cash From Continuing Operating Activities
377 130 406 462 636 229 608 572 752 148 631
Net Income / (Loss) Continuing Operations
229 304 352 414 382 404 462 467 493 479 493
Consolidated Net Income / (Loss)
229 304 352 414 382 404 462 467 493 479 493
Depreciation Expense
29 32 32 36 36 35 37 41 40 41 40
Amortization Expense
45 26 40 37 42 38 46 63 47 77 63
Non-Cash Adjustments To Reconcile Net Income
45 63 85 34 65 79 65 75 -14 28 73
Changes in Operating Assets and Liabilities, net
29 -295 -103 -59 111 -327 -2.00 -74 186 -477 -38
Net Cash From Investing Activities
-41 -35 -776 -48 -50 -121 -1,568 -702 -24 -167 -158
Net Cash From Continuing Investing Activities
-41 -35 -776 -48 -50 -121 -1,568 -702 -24 -167 -158
Purchase of Property, Plant & Equipment
-31 -35 -36 -37 -36 -48 -40 -41 -42 -56 -58
Acquisitions
-10 - -740 -12 -14 -73 -1,599 -661 -29 -111 -99
Divestitures
- - - 1.00 0.00 - - - 47 - -1.00
Net Cash From Financing Activities
-65 1,133 -1,079 -5.00 67 601 -516 3,019 -4,516 -24 -129
Net Cash From Continuing Financing Activities
-65 1,133 -1,079 -5.00 67 601 -516 3,019 -4,516 -24 -129
Repayment of Debt
-1,744 -5,570 5,094 -4,211 -18 -6,116 2,124 2,022 -2.00 -25 -2,671
Repurchase of Common Equity
- - - - 0.00 - - - -316 -53 -131
Issuance of Debt
1,690 6,611 -6,233 4,170 2,071 6,604 -2,688 965 163 - 2,615
Other Financing Activities, net
27 92 60 36 52 113 48 32 35 54 58
Other Net Changes in Cash
16 - - - - - - - - - 22
Cash Interest Paid
272 273 263 352 205 340 232 381 162 435 311
Cash Income Taxes Paid
-2.00 156 77 29 11 339 122 67 37 335 132

Annual Balance Sheets for Transdigm Group

This table presents Transdigm Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2014 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Total Assets
6,757 8,304 10,726 9,976 12,197 16,255 18,395 19,315 18,107 19,970 25,586
Total Current Assets
1,690 1,787 2,931 2,134 3,657 4,865 6,960 7,030 5,649 6,738 10,029
Cash & Equivalents
820 714 1,587 651 2,073 1,467 4,717 4,787 3,001 3,472 6,261
Accounts Receivable
351 444 576 636 704 1,068 720 791 967 1,230 1,381
Inventories, net
459 591 724 731 805 1,233 1,283 1,185 1,332 1,616 1,876
Prepaid Expenses
22 37 43 39 75 135 240 267 349 420 511
Plant, Property, & Equipment, net
212 261 311 325 388 757 752 770 807 1,255 1,488
Total Noncurrent Assets
4,855 6,257 7,485 7,517 8,152 10,633 10,683 11,515 11,651 11,977 14,069
Goodwill
3,525 4,686 5,679 5,745 6,223 7,820 7,889 8,568 8,641 8,988 10,419
Intangible Assets
1,217 1,540 1,764 1,718 1,788 2,744 2,610 2,791 2,750 2,747 3,446
Other Noncurrent Operating Assets
113 31 41 54 140 69 167 156 260 242 204
Total Liabilities & Shareholders' Equity
6,757 8,304 10,726 9,976 12,197 16,255 18,395 19,315 18,107 19,970 25,586
Total Liabilities
8,313 9,342 11,378 12,927 14,006 19,139 22,363 22,225 21,873 21,948 31,869
Total Current Liabilities
586 658 753 871 900 1,538 1,616 1,663 1,426 1,579 6,339
Short-Term Debt
239 243 252 369 375 430 625 626 426 420 584
Accounts Payable
116 143 156 149 174 276 218 227 279 305 323
Accrued Expenses
231 272 344 336 351 675 773 810 721 854 1,216
Dividends Payable
- - - - - - - - - 0.00 4,216
Total Noncurrent Liabilities
7,727 8,685 10,625 12,056 13,106 17,601 20,747 20,562 20,447 20,369 25,530
Long-Term Debt
7,234 8,106 9,943 11,394 12,502 16,469 19,384 19,372 19,369 19,330 24,296
Noncurrent Deferred & Payable Income Tax Liabilities
402 405 492 501 399 441 430 485 596 627 766
Other Noncurrent Operating Liabilities
91 173 190 161 204 691 933 705 482 412 468
Total Equity & Noncontrolling Interests
-1,556 -1,038 -651 -2,951 -1,808 -2,884 -3,968 -2,910 -3,766 -1,978 -6,283
Total Preferred & Common Equity
-1,556 -1,038 -651 -2,951 -1,808 -2,894 -3,972 -2,916 -3,773 -1,984 -6,290
Total Common Equity
-1,556 -1,038 -651 -2,951 -1,808 -2,894 -3,972 -2,916 -3,773 -1,984 -6,290
Common Stock
795 951 1,030 1,096 1,209 1,380 1,582 1,831 2,114 2,441 2,820
Retained Earnings
-2,150 -1,717 -1,147 -3,187 -2,247 -3,120 -4,359 -3,705 -3,914 -2,621 -7,362
Treasury Stock
-176 -176 -384 -775 -775 -775 -794 -794 -1,706 -1,706 -1,706
Accumulated Other Comprehensive Income / (Loss)
-25 -96 -150 -85 4.10 -379 -401 -248 -267 -98 -42
Noncontrolling Interest
- - - - 0.00 10 4.00 6.00 7.00 6.00 7.00

Quarterly Balance Sheets for Transdigm Group

This table presents Transdigm Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 12/31/2022 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/30/2024 12/28/2024 3/29/2025 6/28/2025
Total Assets
18,489 20,008 19,555 19,970 20,685 21,577 21,828 25,586 21,515 21,905 22,700
Total Current Assets
5,929 7,456 6,252 6,738 7,396 8,282 7,061 10,029 6,156 6,408 6,915
Cash & Equivalents
3,288 3,418 3,071 3,472 4,135 4,288 3,360 6,261 2,459 2,426 2,792
Accounts Receivable
860 1,018 1,159 1,230 1,145 1,201 1,300 1,381 1,285 1,442 1,518
Inventories, net
1,439 1,529 1,603 1,616 1,708 1,753 1,878 1,876 1,930 2,010 2,083
Prepaid Expenses
342 391 419 420 408 490 523 511 482 530 522
Plant, Property, & Equipment, net
864 872 983 1,255 1,335 1,288 1,431 1,488 1,477 1,519 1,540
Total Noncurrent Assets
11,696 11,680 12,320 11,977 11,954 12,007 13,336 14,069 13,882 13,978 14,245
Goodwill
8,719 8,743 9,141 8,988 9,036 9,051 10,018 10,419 10,304 10,355 10,548
Intangible Assets
2,750 2,725 2,945 2,747 2,733 2,709 3,116 3,446 3,360 3,422 3,462
Other Noncurrent Operating Assets
227 212 234 242 185 247 202 204 218 201 235
Total Liabilities & Shareholders' Equity
18,489 20,008 19,555 19,970 20,685 21,577 21,828 25,586 21,515 21,905 22,700
Total Liabilities
21,817 22,901 21,942 21,948 24,191 24,599 24,338 31,869 27,766 27,569 27,696
Total Current Liabilities
1,408 2,522 1,533 1,579 1,818 2,235 1,851 6,339 2,284 2,074 2,211
Short-Term Debt
428 1,512 417 420 530 1,075 528 584 747 743 744
Accounts Payable
271 292 292 305 288 302 320 323 315 319 328
Accrued Expenses
709 718 824 854 1,000 858 1,003 1,216 1,222 1,012 1,139
Dividends Payable
- - - 0.00 - - - 4,216 0.00 0.00 0.00
Total Noncurrent Liabilities
20,409 20,379 20,409 20,369 22,373 22,364 22,487 25,530 25,482 25,495 25,485
Long-Term Debt
19,375 19,349 19,348 19,330 21,346 21,331 21,364 24,296 24,302 24,306 24,268
Noncurrent Deferred & Payable Income Tax Liabilities
607 599 619 627 611 606 708 766 762 761 766
Other Noncurrent Operating Liabilities
427 431 442 412 416 427 415 468 418 428 451
Total Equity & Noncontrolling Interests
-3,328 -2,893 -2,387 -1,978 -3,506 -3,022 -2,510 -6,283 -6,251 -5,664 -4,996
Total Preferred & Common Equity
-3,336 -2,901 -2,394 -1,984 -3,513 -3,029 -2,518 -6,290 -6,258 -5,671 -5,004
Total Common Equity
-3,336 -2,901 -2,394 -1,984 -3,513 -3,029 -2,518 -6,290 -6,258 -5,671 -5,004
Common Stock
2,165 2,285 2,376 2,441 2,519 2,665 2,750 2,820 2,888 2,982 3,078
Retained Earnings
-3,687 -3,384 -3,034 -2,621 -4,266 -3,870 -3,416 -7,362 -6,877 -6,407 -5,924
Treasury Stock
-1,706 -1,706 -1,706 -1,706 -1,706 -1,706 -1,706 -1,706 -2,022 -2,075 -2,206
Accumulated Other Comprehensive Income / (Loss)
-108 -96 -30 -98 -60 -118 -146 -42 -247 -171 48
Noncontrolling Interest
8.00 8.00 7.00 6.00 7.00 7.00 8.00 7.00 7.00 7.00 8.00

Annual Metrics And Ratios for Transdigm Group

This table displays calculated financial ratios and metrics derived from Transdigm Group's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 9/30/2014 9/30/2015 9/30/2016 9/30/2017 9/30/2018 9/30/2019 9/30/2020 9/30/2021 9/30/2022 9/30/2023 9/30/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
23.31% 14.08% 17.15% 10.50% 8.75% 37.05% -2.30% -5.98% 13.15% 21.29% 20.58%
EBITDA Growth
22.67% 14.01% 20.38% 18.28% 9.05% 22.34% -4.73% -0.43% 18.54% 28.83% 21.29%
EBIT Growth
23.80% 15.76% 18.04% 16.73% 11.84% 16.31% -6.65% 0.78% 21.70% 33.21% 21.22%
NOPAT Growth
25.48% 18.79% 28.33% 14.99% 45.08% -5.63% 1.40% 4.24% 5.68% 30.00% 23.56%
Net Income Growth
1.36% 45.71% 31.13% 1.79% 60.33% -6.79% -21.52% -2.71% 27.31% 49.83% 32.02%
EPS Growth
32.22% 148.10% 32.53% -24.16% 105.58% -14.57% -35.26% 16.18% 28.72% 64.40% 16.30%
Operating Cash Flow Growth
34.21% -56.07% 469.92% 15.43% 29.57% -0.68% 19.51% -24.73% 3.83% 45.04% 48.73%
Free Cash Flow Firm Growth
251.96% -352.85% 47.42% 347.30% -25.77% -270.01% 260.54% -67.74% 53.89% -3.52% -48.77%
Invested Capital Growth
7.15% 29.42% 20.61% 1.80% 11.05% 30.54% -3.57% 8.63% 5.91% 9.76% 15.75%
Revenue Q/Q Growth
4.51% 6.60% 2.11% 1.41% 3.40% 10.39% -6.73% 2.24% 4.46% 5.48% 4.39%
EBITDA Q/Q Growth
3.87% 5.07% 4.70% 5.83% 0.77% 7.80% -9.93% 13.12% 1.88% 7.14% 2.39%
EBIT Q/Q Growth
6.05% 5.33% 2.92% 4.15% 2.76% 8.85% -12.89% 12.69% 4.31% 7.94% 2.71%
NOPAT Q/Q Growth
7.90% 5.51% 3.96% 4.48% 4.18% 11.69% -10.62% -3.76% 4.91% 8.60% 3.17%
Net Income Q/Q Growth
10.93% 6.53% 2.27% -0.20% -12.92% 60.88% -27.61% 22.92% 6.91% 12.96% 3.25%
EPS Q/Q Growth
203.85% 8.44% 2.57% -12.74% 18.25% 3.83% -26.26% 0.00% 0.00% 17.62% -5.25%
Operating Cash Flow Q/Q Growth
9,088.22% -60.89% 36.18% 165.23% -26.12% -7.65% -2.02% 7.92% -1.66% 15.94% 5.68%
Free Cash Flow Firm Q/Q Growth
-13.09% -51.49% 23.91% 70.15% -13.96% 51.93% -39.88% -0.29% 3.91% 23.21% -48.46%
Invested Capital Q/Q Growth
0.39% 4.98% 2.93% -1.53% 0.63% -8.61% 0.11% -0.39% -0.04% -0.05% 3.31%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
53.43% 53.56% 54.49% 56.63% 57.12% 53.78% 51.87% 52.38% 57.08% 58.34% 58.84%
EBITDA Margin
43.16% 43.13% 44.32% 47.44% 47.57% 42.47% 41.41% 43.85% 45.94% 48.79% 49.08%
Operating Margin
39.10% 39.67% 39.97% 42.32% 43.43% 36.88% 34.31% 35.24% 40.80% 44.39% 44.47%
EBIT Margin
39.10% 39.67% 39.97% 42.23% 43.43% 36.86% 35.21% 37.74% 40.60% 44.59% 44.82%
Profit (Net Income) Margin
12.93% 16.52% 18.49% 17.03% 25.11% 17.08% 13.72% 14.19% 15.97% 19.73% 21.60%
Tax Burden Percent
68.43% 70.23% 76.34% 71.28% 97.06% 83.91% 94.59% 95.24% 76.93% 75.70% 77.43%
Interest Burden Percent
48.34% 59.29% 60.59% 56.59% 59.58% 55.22% 41.18% 39.48% 51.13% 58.45% 62.24%
Effective Tax Rate
31.57% 29.77% 23.66% 24.94% 2.43% 20.88% 11.76% 4.76% 23.16% 24.30% 22.57%
Return on Invested Capital (ROIC)
12.88% 12.90% 13.30% 13.86% 18.89% 14.69% 13.40% 13.63% 13.44% 16.19% 17.72%
ROIC Less NNEP Spread (ROIC-NNEP)
7.30% 8.60% 8.60% 8.61% 12.87% 9.73% 7.75% 7.54% 8.22% 10.67% 12.51%
Return on Net Nonoperating Assets (RNNOA)
-45.32% -47.37% -82.71% -47.00% -59.10% -52.71% -33.83% -33.44% -39.41% -61.42% -59.24%
Return on Equity (ROE)
-32.43% -34.48% -69.41% -33.14% -40.21% -38.02% -20.43% -19.80% -25.97% -45.23% -41.52%
Cash Return on Invested Capital (CROIC)
5.98% -12.75% -5.39% 12.07% 8.42% -11.80% 17.03% 5.36% 7.70% 6.88% 3.12%
Operating Return on Assets (OROA)
14.38% 14.26% 13.32% 14.30% 14.93% 13.53% 10.37% 9.60% 11.78% 15.42% 15.62%
Return on Assets (ROA)
4.76% 5.94% 6.16% 5.77% 8.63% 6.27% 4.04% 3.61% 4.63% 6.82% 7.53%
Return on Common Equity (ROCE)
-32.43% -34.48% -69.41% -33.14% -40.21% -38.10% -20.47% -19.83% -26.02% -45.33% -41.59%
Return on Equity Simple (ROE_SIMPLE)
-19.72% -43.07% -90.01% -20.23% -52.92% -30.82% -17.62% -23.35% -22.98% -65.47% -27.27%
Net Operating Profit after Tax (NOPAT)
635 754 968 1,113 1,615 1,524 1,545 1,611 1,702 2,213 2,734
NOPAT Margin
26.76% 27.86% 30.52% 31.76% 42.37% 29.17% 30.28% 33.57% 31.35% 33.60% 34.43%
Net Nonoperating Expense Percent (NNEP)
5.58% 4.30% 4.70% 5.25% 6.02% 4.97% 5.65% 6.10% 5.22% 5.53% 5.21%
Cost of Revenue to Revenue
46.57% 46.44% 45.51% 43.37% 42.88% 46.22% 48.13% 47.62% 42.92% 41.66% 41.16%
SG&A Expenses to Revenue
11.65% 11.88% 12.07% 11.77% 11.81% 14.32% 14.25% 14.28% 13.78% 11.85% 12.34%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
14.33% 13.88% 14.51% 14.32% 13.70% 16.91% 17.56% 17.13% 16.28% 13.96% 14.37%
Earnings before Interest and Taxes (EBIT)
928 1,074 1,268 1,480 1,655 1,925 1,797 1,811 2,204 2,936 3,559
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,024 1,168 1,406 1,663 1,813 2,218 2,113 2,104 2,494 3,213 3,897
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.89 2.96 3.42 3.17 4.31 4.71 4.73 6.73 4.79 6.45 9.55
Price to Earnings (P/E)
22.32 17.93 18.61 18.62 17.15 27.67 34.56 47.47 30.03 32.75 44.25
Dividend Yield
36.16% 0.00% 0.00% 21.48% 0.00% 6.50% 14.03% 0.00% 3.86% 0.00% 2.59%
Earnings Yield
4.48% 5.58% 5.37% 5.37% 5.83% 3.61% 2.89% 2.11% 3.33% 3.05% 2.26%
Enterprise Value to Invested Capital (EV/IC)
2.65 2.37 2.45 2.74 3.03 3.41 3.48 3.86 3.29 4.11 5.71
Enterprise Value to Revenue (EV/Rev)
5.69 5.78 6.14 6.34 7.14 7.67 7.73 9.90 7.88 8.93 11.90
Enterprise Value to EBITDA (EV/EBITDA)
13.19 13.41 13.85 13.37 15.01 18.06 18.67 22.58 17.16 18.30 24.24
Enterprise Value to EBIT (EV/EBIT)
14.56 14.58 15.36 15.02 16.44 20.81 21.95 26.23 19.42 20.02 26.54
Enterprise Value to NOPAT (EV/NOPAT)
21.27 20.76 20.12 19.97 16.85 26.30 25.53 29.49 25.15 26.57 34.56
Enterprise Value to Operating Cash Flow (EV/OCF)
49.49 130.57 28.49 28.18 26.63 39.48 32.52 52.03 45.15 42.76 46.20
Enterprise Value to Free Cash Flow (EV/FCFF)
45.80 0.00 0.00 22.93 37.82 0.00 20.09 74.97 43.90 62.50 196.03
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-4.80 -8.04 -15.65 -3.99 -7.12 -5.86 -5.04 -6.87 -5.26 -9.98 -3.96
Long-Term Debt to Equity
-4.65 -7.81 -15.26 -3.86 -6.91 -5.71 -4.89 -6.66 -5.14 -9.77 -3.87
Financial Leverage
-6.21 -5.51 -9.61 -5.46 -4.59 -5.42 -4.37 -4.43 -4.79 -5.76 -4.73
Leverage Ratio
-6.82 -5.81 -11.26 -5.75 -4.66 -6.06 -5.06 -5.48 -5.61 -6.63 -5.51
Compound Leverage Factor
-3.30 -3.44 -6.82 -3.25 -2.78 -3.35 -2.08 -2.16 -2.87 -3.87 -3.43
Debt to Total Capital
126.30% 114.20% 106.83% 133.49% 116.34% 120.58% 124.74% 117.03% 123.49% 111.13% 133.79%
Short-Term Debt to Total Capital
4.04% 3.33% 2.64% 4.19% 3.39% 3.07% 3.90% 3.66% 2.66% 2.36% 3.14%
Long-Term Debt to Total Capital
122.25% 110.87% 104.18% 129.30% 112.95% 117.51% 120.84% 113.37% 120.84% 108.77% 130.64%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.07% 0.02% 0.04% 0.04% 0.03% 0.04%
Common Equity to Total Capital
-26.30% -14.20% -6.83% -33.49% -16.34% -20.65% -24.76% -17.06% -23.54% -11.16% -33.82%
Debt to EBITDA
7.30 7.15 7.25 7.08 7.10 7.62 9.47 9.50 7.94 6.15 6.38
Net Debt to EBITDA
6.50 6.54 6.12 6.68 5.96 6.96 7.24 7.23 6.73 5.07 4.78
Long-Term Debt to EBITDA
7.06 6.94 7.07 6.85 6.90 7.43 9.17 9.21 7.77 6.02 6.23
Debt to NOPAT
11.77 11.07 10.53 10.57 7.98 11.09 12.95 12.42 11.63 8.93 9.10
Net Debt to NOPAT
10.48 10.12 8.89 9.98 6.69 10.13 9.90 9.44 9.87 7.36 6.81
Long-Term Debt to NOPAT
11.39 10.75 10.27 10.24 7.74 10.81 12.55 12.03 11.38 8.74 8.89
Altman Z-Score
1.05 1.14 1.35 1.06 1.48 1.46 1.26 1.49 1.39 2.10 1.97
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% -0.21% -0.20% -0.15% -0.19% -0.23% -0.16%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.88 2.72 3.89 2.45 4.06 3.16 4.31 4.23 3.96 4.27 1.58
Quick Ratio
2.00 1.76 2.87 1.48 3.08 1.65 3.36 3.35 2.78 2.98 1.21
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
295 -746 -392 969 720 -1,223 1,964 634 975 941 482
Operating Cash Flow to CapEx
799.19% 218.50% 1,553.59% 1,110.69% 1,400.00% 995.10% 1,155.24% 869.52% 796.64% 989.21% 1,239.39%
Free Cash Flow to Firm to Interest Expense
0.62 -1.71 -0.78 1.51 1.08 -1.42 1.86 0.58 0.91 0.77 0.36
Operating Cash Flow to Interest Expense
0.57 0.27 1.37 1.23 1.53 1.18 1.15 0.83 0.88 1.13 1.52
Operating Cash Flow Less CapEx to Interest Expense
0.50 0.15 1.28 1.12 1.42 1.06 1.05 0.74 0.77 1.01 1.40
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.37 0.36 0.33 0.34 0.34 0.37 0.29 0.25 0.29 0.35 0.35
Accounts Receivable Turnover
7.40 6.81 6.22 5.78 5.69 5.89 5.71 6.35 6.18 5.99 6.08
Inventory Turnover
2.53 2.39 2.19 2.09 2.13 2.37 1.95 1.85 1.85 1.86 1.87
Fixed Asset Turnover
11.27 11.45 11.10 11.03 10.69 9.12 6.76 6.30 6.89 6.39 5.79
Accounts Payable Turnover
9.93 9.73 9.66 9.97 10.14 10.74 9.94 10.27 9.21 9.39 10.41
Days Sales Outstanding (DSO)
49.36 53.62 58.72 63.14 64.19 61.93 63.94 57.47 59.10 60.89 60.01
Days Inventory Outstanding (DIO)
144.12 152.48 166.32 174.70 171.55 154.10 186.96 197.12 197.15 196.14 195.01
Days Payable Outstanding (DPO)
36.75 37.53 37.79 36.61 36.00 33.99 36.71 35.54 39.63 38.86 35.07
Cash Conversion Cycle (CCC)
156.73 168.57 187.25 201.23 199.74 182.03 214.20 219.05 216.61 218.17 219.95
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,097 6,597 7,957 8,101 8,996 11,743 11,324 12,301 13,028 14,300 16,552
Invested Capital Turnover
0.48 0.46 0.44 0.44 0.45 0.50 0.44 0.41 0.43 0.48 0.51
Increase / (Decrease) in Invested Capital
340 1,500 1,360 144 895 2,747 -419 977 727 1,272 2,252
Enterprise Value (EV)
13,505 15,654 19,469 22,227 27,214 40,068 39,450 47,500 42,804 58,789 94,472
Market Capitalization
6,852 8,019 10,860 11,115 16,410 24,626 24,154 32,283 26,003 42,505 75,846
Book Value per Share
($29.52) ($19.40) ($12.23) ($56.85) ($34.36) ($54.27) ($73.28) ($52.91) ($69.57) ($35.95) ($112.10)
Tangible Book Value per Share
($119.49) ($135.70) ($151.98) ($200.62) ($186.59) ($252.36) ($266.96) ($259.02) ($279.60) ($248.61) ($359.20)
Total Capital
5,917 7,311 9,544 8,811 11,069 14,015 16,041 17,088 16,029 17,772 18,597
Total Debt
7,473 8,350 10,196 11,763 12,877 16,899 20,009 19,998 19,795 19,750 24,880
Total Long-Term Debt
7,234 8,106 9,943 11,394 12,502 16,469 19,384 19,372 19,369 19,330 24,296
Net Debt
6,654 7,636 8,609 11,112 10,804 15,432 15,292 15,211 16,794 16,278 18,619
Capital Expenditures (CapEx)
34 55 44 71 73 102 105 105 119 139 165
Debt-free, Cash-free Net Working Capital (DFCFNWC)
523 658 844 981 1,059 2,290 1,252 1,206 1,648 2,107 -1,987
Debt-free Net Working Capital (DFNWC)
1,343 1,372 2,431 1,632 3,132 3,757 5,969 5,993 4,649 5,579 4,274
Net Working Capital (NWC)
1,104 1,129 2,178 1,263 2,757 3,327 5,344 5,367 4,223 5,159 3,690
Net Nonoperating Expense (NNE)
328 307 381 516 658 632 845 930 835 914 1,019
Net Nonoperating Obligations (NNO)
6,654 7,636 8,609 11,052 10,804 14,627 15,292 15,211 16,794 16,278 22,835
Total Depreciation and Amortization (D&A)
96 94 138 183 158 293 316 293 290 277 338
Debt-free, Cash-free Net Working Capital to Revenue
22.06% 24.31% 26.60% 28.00% 27.79% 43.84% 24.53% 25.14% 30.36% 32.00% -25.03%
Debt-free Net Working Capital to Revenue
56.60% 50.69% 76.64% 46.56% 82.19% 71.93% 116.97% 124.91% 85.63% 84.72% 53.83%
Net Working Capital to Revenue
46.51% 41.70% 68.68% 36.03% 72.34% 63.70% 104.72% 111.86% 77.79% 78.34% 46.47%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.16 $7.84 $10.39 $7.88 $16.20 $13.84 $8.96 $10.41 $13.40 $22.03 $25.62
Adjusted Weighted Average Basic Shares Outstanding
52.46M 53.69M 53.35M 51.96M 52.75M 53.55M 54.44M 55.25M 58.20M 57.20M 57.80M
Adjusted Diluted Earnings per Share
$3.16 $7.84 $10.39 $7.88 $16.20 $13.84 $8.96 $10.41 $13.40 $22.03 $25.62
Adjusted Weighted Average Diluted Shares Outstanding
52.46M 53.69M 53.35M 51.96M 52.75M 53.55M 54.44M 55.25M 58.20M 57.20M 57.80M
Adjusted Basic & Diluted Earnings per Share
$3.16 $7.84 $10.39 $7.88 $16.20 $13.84 $8.96 $10.41 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
56.99M 56.61M 56.16M 55.53M 55.60M 56.27M 57.30M 58.40M 54.37M 55.31M 56.23M
Normalized Net Operating Profit after Tax (NOPAT)
635 754 968 1,113 1,615 1,524 1,545 1,611 1,702 2,213 2,734
Normalized NOPAT Margin
26.76% 27.86% 30.52% 31.76% 42.37% 29.17% 30.28% 33.57% 31.35% 33.60% 34.43%
Pre Tax Income Margin
18.90% 23.52% 24.22% 23.90% 25.87% 20.35% 14.50% 14.90% 20.76% 26.06% 27.90%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.94 2.46 2.54 2.30 2.47 2.23 1.70 1.65 2.05 2.41 2.65
NOPAT to Interest Expense
1.32 1.73 1.94 1.73 2.41 1.77 1.46 1.47 1.58 1.81 2.03
EBIT Less CapEx to Interest Expense
1.86 2.33 2.45 2.19 2.36 2.11 1.60 1.56 1.94 2.29 2.53
NOPAT Less CapEx to Interest Expense
1.25 1.60 1.85 1.62 2.30 1.65 1.36 1.37 1.47 1.70 1.91
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
472.90% 0.75% 0.51% 432.50% 5.85% 191.93% 275.43% 10.72% 125.84% 2.93% 118.83%
Augmented Payout Ratio
524.99% 0.75% 35.94% 497.81% 5.85% 191.93% 278.14% 10.72% 231.03% 2.93% 118.83%

Quarterly Metrics And Ratios for Transdigm Group

This table displays calculated financial ratios and metrics derived from Transdigm Group's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 12/31/2022 4/1/2023 7/1/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/30/2024 12/28/2024 3/29/2025 6/28/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
17.00% 19.97% 24.75% 22.65% 28.06% 20.54% 17.32% 18.03% 12.13% 12.04% 9.34%
EBITDA Growth
28.38% 27.97% 28.76% 29.93% 30.23% 25.30% 19.33% 13.46% 25.17% 16.10% 12.62%
EBIT Growth
29.32% 32.51% 36.32% 33.75% 33.33% 25.25% 19.70% 10.98% 26.52% 14.55% 9.60%
NOPAT Growth
16.81% 33.72% 28.07% 37.40% 37.25% 26.81% 21.71% 12.95% 25.92% 13.08% 12.78%
Net Income Growth
39.63% 52.76% 47.28% 56.23% 66.81% 32.89% 30.97% 13.04% 29.06% 18.56% 6.94%
EPS Growth
68.18% 57.40% 49.76% 83.76% 46.25% 31.02% 29.64% -19.61% 56.47% 18.22% 6.41%
Operating Cash Flow Growth
35.13% 49.43% 31.39% 69.23% 68.70% 76.15% 49.75% 23.81% 18.24% -35.37% 3.78%
Free Cash Flow Firm Growth
39.35% -271.27% -204.83% -143.35% -18.95% -106.62% -45.67% -142.93% -207.51% -291.78% 60.46%
Invested Capital Growth
6.56% 5.79% 9.78% 9.76% 7.95% 8.15% 11.99% 15.75% 14.78% 16.59% 7.50%
Revenue Q/Q Growth
-7.48% 13.96% 9.55% 6.19% -3.40% 7.27% 6.62% 6.84% -8.23% 7.18% 4.05%
EBITDA Q/Q Growth
-6.99% 13.53% 14.44% 7.52% -6.78% 9.24% 8.99% 2.23% 2.85% 3.14% 2.15%
EBIT Q/Q Growth
-7.66% 17.94% 13.63% 8.08% -7.94% 10.79% 8.59% 0.21% 4.95% 0.30% 3.90%
NOPAT Q/Q Growth
-4.34% 18.56% 10.42% 9.71% -4.45% 9.55% 5.98% 1.82% 6.52% -1.62% 5.70%
Net Income Q/Q Growth
-13.58% 32.75% 15.79% 17.61% -7.73% 5.76% 14.11% 1.52% 5.34% -2.84% 2.92%
EPS Q/Q Growth
-15.48% 59.76% 15.41% 17.92% -32.73% 43.12% 14.20% -26.88% 30.93% 8.14% 2.79%
Operating Cash Flow Q/Q Growth
38.10% -65.52% 212.31% 13.79% 37.66% -63.99% 165.50% -5.92% 31.47% -80.32% 326.35%
Free Cash Flow Firm Q/Q Growth
-40.88% 43.87% -236.75% 8.61% 31.14% 2.51% -137.41% -52.41% 12.83% -24.21% 76.04%
Invested Capital Q/Q Growth
1.22% 1.99% 6.37% -0.05% -0.45% 2.18% 10.15% 3.31% -1.29% 3.79% 1.56%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
56.76% 58.35% 59.00% 58.91% 58.24% 60.03% 59.63% 57.55% 61.57% 59.26% 59.54%
EBITDA Margin
47.60% 47.42% 49.54% 50.16% 48.41% 49.30% 50.39% 48.22% 54.04% 52.00% 51.05%
Operating Margin
42.23% 43.66% 44.90% 46.17% 43.99% 45.18% 45.65% 43.14% 48.55% 46.09% 46.45%
EBIT Margin
42.30% 43.78% 45.41% 46.22% 44.05% 45.49% 46.33% 43.46% 49.70% 46.51% 46.45%
Profit (Net Income) Margin
16.39% 19.10% 20.18% 22.35% 21.35% 21.05% 22.53% 21.41% 24.58% 22.28% 22.04%
Tax Burden Percent
76.08% 76.57% 75.05% 75.41% 78.28% 77.84% 76.58% 77.23% 79.64% 77.01% 77.64%
Interest Burden Percent
50.93% 56.96% 59.22% 64.14% 61.93% 59.45% 63.50% 63.79% 62.09% 62.20% 61.12%
Effective Tax Rate
23.92% 23.43% 24.95% 24.59% 21.72% 22.16% 23.42% 22.77% 20.36% 22.99% 22.36%
Return on Invested Capital (ROIC)
14.16% 15.07% 15.39% 16.78% 17.52% 18.35% 17.53% 17.15% 20.63% 18.90% 18.61%
ROIC Less NNEP Spread (ROIC-NNEP)
12.76% 13.64% 13.95% 15.38% 16.16% 16.75% 16.09% 15.82% 19.23% 17.49% 17.07%
Return on Net Nonoperating Assets (RNNOA)
-67.56% -75.32% -85.16% -88.57% -80.99% -96.05% -115.74% -74.89% -79.50% -80.91% -92.68%
Return on Equity (ROE)
-53.40% -60.25% -69.77% -71.79% -63.46% -77.70% -98.21% -57.74% -58.86% -62.01% -74.07%
Cash Return on Invested Capital (CROIC)
7.52% 8.96% 5.59% 6.88% 9.72% 10.19% 6.17% 3.12% 5.17% 3.61% 11.26%
Operating Return on Assets (OROA)
12.63% 13.29% 14.78% 15.99% 15.69% 15.98% 17.03% 15.15% 19.21% 17.94% 17.90%
Return on Assets (ROA)
4.89% 5.80% 6.57% 7.73% 7.61% 7.40% 8.28% 7.46% 9.50% 8.60% 8.49%
Return on Common Equity (ROCE)
-53.54% -60.40% -69.96% -71.95% -63.60% -77.89% -98.51% -57.83% -58.95% -62.11% -74.23%
Return on Equity Simple (ROE_SIMPLE)
-27.94% -35.75% -48.04% 0.00% -41.33% -51.24% -65.97% 0.00% -29.18% -33.52% 0.00%
Net Operating Profit after Tax (NOPAT)
449 532 588 645 616 675 715 728 776 763 807
NOPAT Margin
32.13% 33.43% 33.70% 34.81% 34.44% 35.17% 34.96% 33.31% 38.67% 35.50% 36.06%
Net Nonoperating Expense Percent (NNEP)
1.40% 1.43% 1.44% 1.40% 1.37% 1.60% 1.44% 1.33% 1.40% 1.41% 1.54%
Return On Investment Capital (ROIC_SIMPLE)
- - - - 3.35% - - - 4.13% 3.94% 4.03%
Cost of Revenue to Revenue
43.24% 41.65% 41.00% 41.09% 41.76% 39.97% 40.37% 42.45% 38.43% 40.74% 40.46%
SG&A Expenses to Revenue
12.10% 12.50% 11.98% 10.96% 12.30% 12.92% 12.12% 12.08% 10.52% 10.98% 10.82%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
14.53% 14.70% 14.11% 12.74% 14.25% 14.85% 13.98% 14.41% 13.01% 13.16% 13.10%
Earnings before Interest and Taxes (EBIT)
591 697 792 856 788 873 948 950 997 1,000 1,039
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
665 755 864 929 866 946 1,031 1,054 1,084 1,118 1,142
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
5.86 6.58 7.59 6.45 7.60 9.38 9.40 9.55 8.90 9.21 9.82
Price to Earnings (P/E)
35.47 37.47 41.23 32.75 36.50 44.16 43.04 44.25 39.77 40.63 43.58
Dividend Yield
3.05% 2.60% 2.15% 0.00% 3.65% 2.84% 2.74% 2.59% 8.52% 7.99% 7.34%
Earnings Yield
2.82% 2.67% 2.43% 3.05% 2.74% 2.26% 2.32% 2.26% 2.51% 2.46% 2.29%
Enterprise Value to Invested Capital (EV/IC)
3.76 4.10 4.48 4.11 4.97 5.92 5.62 5.71 5.83 5.89 6.18
Enterprise Value to Revenue (EV/Rev)
8.80 9.35 10.26 8.93 10.14 11.78 11.84 11.90 11.67 11.91 12.41
Enterprise Value to EBITDA (EV/EBITDA)
18.76 19.66 21.37 18.30 20.72 23.65 23.66 24.24 23.13 23.39 24.20
Enterprise Value to EBIT (EV/EBIT)
21.19 21.99 23.56 20.02 22.58 26.01 25.98 26.54 25.26 25.64 26.70
Enterprise Value to NOPAT (EV/NOPAT)
27.94 28.91 31.45 26.57 29.72 34.11 33.97 34.56 32.89 33.49 34.62
Enterprise Value to Operating Cash Flow (EV/OCF)
47.37 50.66 54.03 42.76 43.30 49.66 46.53 46.20 44.05 48.01 50.61
Enterprise Value to Free Cash Flow (EV/FCFF)
51.53 47.05 83.92 62.50 53.09 60.31 96.29 196.03 120.50 175.43 56.86
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-5.95 -7.21 -8.28 -9.98 -6.24 -7.41 -8.72 -3.96 -4.01 -4.42 -5.01
Long-Term Debt to Equity
-5.82 -6.69 -8.11 -9.77 -6.09 -7.06 -8.51 -3.87 -3.89 -4.29 -4.86
Financial Leverage
-5.29 -5.52 -6.11 -5.76 -5.01 -5.73 -7.19 -4.73 -4.13 -4.63 -5.43
Leverage Ratio
-6.34 -6.71 -7.17 -6.63 -5.73 -7.03 -8.45 -5.51 -4.33 -5.01 -5.93
Compound Leverage Factor
-3.23 -3.82 -4.24 -4.25 -3.55 -4.18 -5.37 -3.52 -2.69 -3.11 -3.63
Debt to Total Capital
120.20% 116.10% 113.74% 111.13% 119.09% 115.59% 112.95% 133.79% 133.25% 129.22% 124.96%
Short-Term Debt to Total Capital
2.60% 8.42% 2.40% 2.36% 2.89% 5.55% 2.72% 3.14% 3.97% 3.83% 3.72%
Long-Term Debt to Total Capital
117.60% 107.69% 111.34% 108.77% 116.20% 110.04% 110.23% 130.64% 129.28% 125.39% 121.24%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.05% 0.04% 0.04% 0.03% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
Common Equity to Total Capital
-20.25% -16.15% -13.78% -11.16% -19.12% -15.63% -12.99% -33.82% -33.29% -29.25% -25.00%
Debt to EBITDA
7.50 7.43 6.59 6.15 6.41 6.16 5.75 6.38 6.09 5.87 5.69
Net Debt to EBITDA
6.25 5.82 5.57 5.07 5.20 4.83 4.87 4.78 5.49 5.30 5.05
Long-Term Debt to EBITDA
7.34 6.90 6.45 6.02 6.25 5.86 5.61 6.23 5.91 5.69 5.52
Debt to NOPAT
11.17 10.93 9.70 8.93 9.19 8.88 8.26 9.10 8.66 8.40 8.14
Net Debt to NOPAT
9.31 8.56 8.19 7.36 7.45 6.96 6.99 6.81 7.81 7.59 7.23
Long-Term Debt to NOPAT
10.93 10.14 9.50 8.74 8.97 8.45 8.06 8.89 8.40 8.15 7.89
Altman Z-Score
1.33 1.49 1.82 1.76 1.81 2.23 2.32 1.63 1.87 2.04 2.24
Noncontrolling Interest Sharing Ratio
-0.25% -0.24% -0.28% -0.23% -0.22% -0.25% -0.31% -0.16% -0.14% -0.16% -0.21%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.21 2.96 4.08 4.27 4.07 3.71 3.81 1.58 2.70 3.09 3.13
Quick Ratio
2.95 1.76 2.76 2.98 2.90 2.46 2.52 1.21 1.64 1.87 1.95
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-363 -204 -686 -627 -432 -421 -1,000 -1,524 -1,328 -1,650 -395
Operating Cash Flow to CapEx
1,216.13% 371.43% 1,127.78% 1,248.65% 1,766.67% 477.08% 1,520.00% 1,395.12% 1,790.48% 264.29% 1,087.93%
Free Cash Flow to Firm to Interest Expense
-1.25 -0.68 -2.12 -2.04 -1.44 -1.19 -2.89 -4.43 -3.51 -4.36 -0.98
Operating Cash Flow to Interest Expense
1.30 0.43 1.26 1.50 2.12 0.65 1.76 1.66 1.99 0.39 1.56
Operating Cash Flow Less CapEx to Interest Expense
1.19 0.32 1.15 1.38 2.00 0.51 1.64 1.54 1.88 0.24 1.42
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.30 0.30 0.33 0.35 0.36 0.35 0.37 0.35 0.39 0.39 0.39
Accounts Receivable Turnover
7.35 6.51 6.11 5.99 6.96 6.58 6.19 6.08 6.71 6.35 6.09
Inventory Turnover
1.81 1.78 1.78 1.86 1.83 1.82 1.78 1.87 1.81 1.81 1.76
Fixed Asset Turnover
6.79 7.01 6.95 6.39 6.35 6.76 6.30 5.79 5.80 5.98 5.78
Accounts Payable Turnover
9.94 9.33 9.65 9.39 10.33 10.07 10.13 10.41 10.92 10.95 10.74
Days Sales Outstanding (DSO)
49.68 56.08 59.69 60.89 52.45 55.44 59.00 60.01 54.37 57.50 59.95
Days Inventory Outstanding (DIO)
201.73 204.49 204.70 196.14 199.00 200.32 204.86 195.01 201.68 201.93 207.72
Days Payable Outstanding (DPO)
36.71 39.11 37.82 38.86 35.35 36.26 36.02 35.07 33.43 33.32 33.98
Cash Conversion Cycle (CCC)
214.69 221.46 226.58 218.17 216.10 219.51 227.85 219.95 222.62 226.11 233.69
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
13,187 13,450 14,307 14,300 14,235 14,546 16,022 16,552 16,339 16,959 17,224
Invested Capital Turnover
0.44 0.45 0.46 0.48 0.51 0.52 0.50 0.51 0.53 0.53 0.52
Increase / (Decrease) in Invested Capital
812 736 1,274 1,272 1,048 1,096 1,715 2,252 2,104 2,413 1,202
Enterprise Value (EV)
49,546 55,165 64,074 58,789 70,746 86,060 90,033 94,472 95,185 99,870 106,432
Market Capitalization
33,023 38,814 47,373 42,505 52,998 68,485 71,493 75,846 72,588 77,240 84,204
Book Value per Share
($61.35) ($53.13) ($43.58) ($35.95) ($63.51) ($54.47) ($45.00) ($112.10) ($111.29) ($101.12) ($89.09)
Tangible Book Value per Share
($272.28) ($263.18) ($263.62) ($248.61) ($276.28) ($265.96) ($279.71) ($359.20) ($354.29) ($346.76) ($338.53)
Total Capital
16,475 17,968 17,378 17,772 18,370 19,384 19,382 18,597 18,798 19,385 20,016
Total Debt
19,803 20,861 19,765 19,750 21,876 22,406 21,892 24,880 25,049 25,049 25,012
Total Long-Term Debt
19,375 19,349 19,348 19,330 21,346 21,331 21,364 24,296 24,302 24,306 24,268
Net Debt
16,515 16,343 16,694 16,278 17,741 17,568 18,532 18,619 22,590 22,623 22,220
Capital Expenditures (CapEx)
31 35 36 37 36 48 40 41 42 56 58
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,661 1,928 2,065 2,107 1,973 2,284 2,378 -1,987 2,160 2,651 2,656
Debt-free Net Working Capital (DFNWC)
4,949 6,446 5,136 5,579 6,108 7,122 5,738 4,274 4,619 5,077 5,448
Net Working Capital (NWC)
4,521 4,934 4,719 5,159 5,578 6,047 5,210 3,690 3,872 4,334 4,704
Net Nonoperating Expense (NNE)
220 228 236 231 234 271 254 260 283 284 314
Net Nonoperating Obligations (NNO)
16,515 16,343 16,694 16,278 17,741 17,568 18,532 22,835 22,590 22,623 22,220
Total Depreciation and Amortization (D&A)
74 58 72 73 78 73 83 104 87 118 103
Debt-free, Cash-free Net Working Capital to Revenue
29.49% 32.69% 33.08% 32.00% 28.28% 31.27% 31.26% -25.03% 26.48% 31.60% 30.96%
Debt-free Net Working Capital to Revenue
87.87% 109.31% 82.27% 84.72% 87.54% 97.51% 75.44% 53.83% 56.63% 60.53% 63.50%
Net Working Capital to Revenue
80.27% 83.67% 75.59% 78.34% 79.95% 82.79% 68.50% 46.47% 47.47% 51.67% 54.83%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.33 $5.32 $6.14 $7.24 $4.87 $6.97 $7.96 $5.82 $7.62 $8.24 $8.47
Adjusted Weighted Average Basic Shares Outstanding
57.10M 57.10M 57.20M 57.20M 57.70M 57.80M 57.90M 57.80M 58.30M 58.10M 58.10M
Adjusted Diluted Earnings per Share
$3.33 $5.32 $6.14 $7.24 $4.87 $6.97 $7.96 $5.82 $7.62 $8.24 $8.47
Adjusted Weighted Average Diluted Shares Outstanding
57.10M 57.10M 57.20M 57.20M 57.70M 57.80M 57.90M 57.80M 58.30M 58.10M 58.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
54.60M 54.93M 55.18M 55.31M 55.61M 55.96M 56.11M 56.23M 56.08M 56.17M 56.35M
Normalized Net Operating Profit after Tax (NOPAT)
449 532 588 645 616 675 715 728 776 763 807
Normalized NOPAT Margin
32.13% 33.43% 33.70% 34.81% 34.44% 35.17% 34.96% 33.31% 38.67% 35.50% 36.06%
Pre Tax Income Margin
21.55% 24.94% 26.89% 29.64% 27.28% 27.05% 29.42% 27.72% 30.86% 28.93% 28.39%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.04 2.32 2.45 2.79 2.63 2.47 2.74 2.76 2.64 2.65 2.57
NOPAT to Interest Expense
1.55 1.77 1.82 2.10 2.05 1.91 2.07 2.12 2.05 2.02 2.00
EBIT Less CapEx to Interest Expense
1.93 2.21 2.34 2.67 2.51 2.33 2.62 2.64 2.53 2.50 2.43
NOPAT Less CapEx to Interest Expense
1.44 1.66 1.71 1.98 1.93 1.77 1.95 2.00 1.94 1.87 1.85
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
116.20% 104.44% 94.17% 2.93% 140.36% 131.31% 122.70% 118.83% 240.74% 231.25% 227.42%
Augmented Payout Ratio
116.20% 104.44% 94.17% 2.93% 140.36% 131.31% 122.70% 118.83% 258.05% 250.66% 253.29%

Key Financial Trends

Transdigm Group (NYSE: TDG) has demonstrated consistent growth in revenue and earnings over the past several quarters, reflecting steady operational performance and effective cost management.

  • Operating revenue increased from $1.40 billion in Q1 2023 to $2.24 billion in Q3 2025, showing strong top-line growth.
  • Net income attributable to common shareholders rose from $229 million in Q1 2023 to $492 million in Q3 2025, indicating improved profitability.
  • Diluted earnings per share increased from $3.33 in Q1 2023 to $8.47 in Q3 2025, suggesting strong earnings growth on a per-share basis.
  • Gross profit margin has remained robust, with gross profit increasing from $793 million in Q1 2023 to $1.33 billion in Q3 2025, demonstrating effective cost control on revenue.
  • Net cash from continuing operating activities improved to $631 million in Q3 2025 from $377 million in Q1 2023, underscoring strong cash flow generation.
  • Capital expenditures in Q3 2025 were $58 million, relatively stable compared to prior quarters, reflecting ongoing investment in property, plant, and equipment.
  • Acquisitions spending was $99 million in Q3 2025, up from $10 million in Q1 2023, signaling active growth through acquisitions.
  • Total assets increased from $18.5 billion in Q1 2023 to $22.7 billion in Q3 2025, driven by increases in goodwill and intangible assets to support expansion strategies.
  • Total liabilities remain high at approximately $27.7 billion in Q3 2025, with long-term debt increasing from about $19.4 billion in Q1 2023 to $24.3 billion, indicating elevated leverage.
  • Shareholders’ equity remains negative, around -$5 billion in Q3 2025 compared to -$3.3 billion in Q1 2023, which may be a concern implying balance sheet pressure despite profitability.

Summary: Transdigm Group has shown solid revenue and earnings growth along with improving operational cash flow over the past several years. The company is actively investing in acquisitions and maintaining capital expenditures to support continued expansion. However, the elevated long-term debt levels and negative shareholders’ equity highlight financial leverage risks that investors should monitor. Overall, the firm appears fundamentally strong but carries some financial risk linked to its capital structure.

08/09/25 02:20 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Transdigm Group's Financials

When does Transdigm Group's fiscal year end?

According to the most recent income statement we have on file, Transdigm Group's financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has Transdigm Group's net income changed over the last 10 years?

Transdigm Group's net income appears to be on an upward trend, with a most recent value of $1.72 billion in 2024, rising from $306.91 million in 2014. The previous period was $1.30 billion in 2023. See where experts think Transdigm Group is headed by visiting Transdigm Group's forecast page.

What is Transdigm Group's operating income?
Transdigm Group's total operating income in 2024 was $3.53 billion, based on the following breakdown:
  • Total Gross Profit: $4.67 billion
  • Total Operating Expenses: $1.14 billion
How has Transdigm Group's revenue changed over the last 10 years?

Over the last 10 years, Transdigm Group's total revenue changed from $2.37 billion in 2014 to $7.94 billion in 2024, a change of 234.6%.

How much debt does Transdigm Group have?

Transdigm Group's total liabilities were at $31.87 billion at the end of 2024, a 45.2% increase from 2023, and a 283.4% increase since 2014.

How much cash does Transdigm Group have?

In the past 10 years, Transdigm Group's cash and equivalents has ranged from $650.56 million in 2017 to $6.26 billion in 2024, and is currently $6.26 billion as of their latest financial filing in 2024.

How has Transdigm Group's book value per share changed over the last 10 years?

Over the last 10 years, Transdigm Group's book value per share changed from -29.52 in 2014 to -112.10 in 2024, a change of 279.7%.



This page (NYSE:TDG) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners